Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Stacef Plus

Approved

STANDARD

Stacef Plus

Inject Care Parenterals Pvt. Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: a60aa0e2b190c011
Company: Inject Care Parenterals Pvt. Ltd.
Type: Standard

Approval Details

Approval Id: a60aa0e2b190c011
Drug Approval Philippines Name: Stacef Plus
Product Name: Stacef Plus
Registration Number: DR-XY45329
Brand Name: Stacef Plus
Generic Name: Ceftriaxone (as sodium) + Sulbactam (as sodium)
Dosage Form: Powder For Injection (I.M./I.V.)
Dosage Strength: 1 g/ 500 mg
Manufacturer: Inject Care Parenterals Pvt. Ltd.
Trader: India
Importer: Stallion Laboratories Pvt. Ltd.
Distributor: Ambica International Corp.
Issuance Date: 28 March 2023
Expiry Date: 28 March 2028
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

a60aa0e2b190c011

Type

Standard

Back to Philippines FDA Approvals

Stacef Plus - Philippines FDA Drug Approval Details